Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Shock, Cardiogenic | 26 | 2024 | 187 | 4.540 |
Why?
|
| Myocardial Infarction | 13 | 2024 | 1000 | 2.880 |
Why?
|
| Heart Failure | 23 | 2024 | 2127 | 2.830 |
Why?
|
| Heart-Assist Devices | 11 | 2024 | 1026 | 1.620 |
Why?
|
| Heart Transplantation | 7 | 2023 | 854 | 1.620 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2021 | 621 | 1.230 |
Why?
|
| Hospital Mortality | 14 | 2024 | 1009 | 1.100 |
Why?
|
| Registries | 9 | 2024 | 1392 | 1.070 |
Why?
|
| Intra-Aortic Balloon Pumping | 3 | 2021 | 42 | 0.950 |
Why?
|
| Hemodynamics | 8 | 2024 | 845 | 0.940 |
Why?
|
| Ventricular Septal Rupture | 1 | 2021 | 3 | 0.780 |
Why?
|
| Myocarditis | 2 | 2020 | 119 | 0.760 |
Why?
|
| Endocarditis | 3 | 2018 | 101 | 0.700 |
Why?
|
| Coronary Artery Disease | 2 | 2023 | 746 | 0.690 |
Why?
|
| Coronary Disease | 1 | 2023 | 637 | 0.670 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 232 | 0.640 |
Why?
|
| Heart Diseases | 1 | 2023 | 482 | 0.630 |
Why?
|
| Propensity Score | 1 | 2019 | 207 | 0.620 |
Why?
|
| Heart Arrest | 1 | 2022 | 340 | 0.610 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 99 | 0.600 |
Why?
|
| Relaxin | 1 | 2013 | 15 | 0.440 |
Why?
|
| Treatment Outcome | 8 | 2024 | 12129 | 0.420 |
Why?
|
| Humans | 45 | 2024 | 123171 | 0.400 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 203 | 0.390 |
Why?
|
| Middle Aged | 17 | 2024 | 25994 | 0.330 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 490 | 0.260 |
Why?
|
| Aged | 12 | 2024 | 19080 | 0.240 |
Why?
|
| Male | 18 | 2024 | 60084 | 0.220 |
Why?
|
| Allografts | 1 | 2023 | 190 | 0.210 |
Why?
|
| Prognosis | 2 | 2022 | 4507 | 0.210 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 1068 | 0.200 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2023 | 88 | 0.200 |
Why?
|
| Shock | 1 | 2022 | 90 | 0.190 |
Why?
|
| Cardiotonic Agents | 1 | 2023 | 135 | 0.190 |
Why?
|
| Patients | 1 | 2022 | 121 | 0.190 |
Why?
|
| Female | 17 | 2024 | 65500 | 0.190 |
Why?
|
| Ischemia | 1 | 2024 | 344 | 0.190 |
Why?
|
| Consensus | 1 | 2024 | 609 | 0.180 |
Why?
|
| Tertiary Care Centers | 2 | 2023 | 235 | 0.180 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2020 | 17 | 0.180 |
Why?
|
| Febrile Neutropenia | 1 | 2020 | 13 | 0.180 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 85 | 0.170 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2023 | 228 | 0.170 |
Why?
|
| Hospitals | 1 | 2022 | 396 | 0.170 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 311 | 0.170 |
Why?
|
| Coronary Vessels | 1 | 2023 | 526 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 132 | 0.160 |
Why?
|
| Lung Transplantation | 1 | 2023 | 316 | 0.160 |
Why?
|
| Ipilimumab | 1 | 2019 | 45 | 0.160 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2020 | 151 | 0.160 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2019 | 11 | 0.160 |
Why?
|
| Myocardial Reperfusion | 1 | 2019 | 73 | 0.160 |
Why?
|
| Retrospective Studies | 9 | 2024 | 16021 | 0.160 |
Why?
|
| Body Mass Index | 1 | 2024 | 1541 | 0.150 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 360 | 0.150 |
Why?
|
| Equipment Design | 1 | 2019 | 601 | 0.140 |
Why?
|
| Defibrillators, Implantable | 1 | 2020 | 192 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2019 | 143 | 0.140 |
Why?
|
| Cardiac Catheterization | 1 | 2021 | 631 | 0.140 |
Why?
|
| Coronary Angiography | 3 | 2023 | 417 | 0.140 |
Why?
|
| Research Report | 1 | 2017 | 70 | 0.140 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2019 | 105 | 0.140 |
Why?
|
| Hospitalization | 3 | 2023 | 1726 | 0.130 |
Why?
|
| Acute Disease | 2 | 2024 | 1094 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2018 | 196 | 0.130 |
Why?
|
| Pandemics | 2 | 2021 | 1101 | 0.130 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 494 | 0.120 |
Why?
|
| Endocarditis, Bacterial | 1 | 2016 | 129 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2019 | 653 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2016 | 186 | 0.110 |
Why?
|
| Adult | 8 | 2021 | 29062 | 0.110 |
Why?
|
| Telemedicine | 1 | 2020 | 426 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2017 | 391 | 0.110 |
Why?
|
| Pulmonary Artery | 3 | 2023 | 439 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5047 | 0.110 |
Why?
|
| Survival Rate | 3 | 2024 | 1996 | 0.110 |
Why?
|
| Risk Factors | 6 | 2024 | 10010 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2022 | 2585 | 0.100 |
Why?
|
| Drug Monitoring | 1 | 2013 | 157 | 0.100 |
Why?
|
| Catheters | 2 | 2023 | 89 | 0.100 |
Why?
|
| United States | 5 | 2024 | 10631 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 1863 | 0.070 |
Why?
|
| Heart | 2 | 2023 | 723 | 0.070 |
Why?
|
| Global Health | 2 | 2020 | 557 | 0.060 |
Why?
|
| Inpatients | 2 | 2020 | 464 | 0.060 |
Why?
|
| Biomarkers | 1 | 2013 | 2946 | 0.060 |
Why?
|
| Extremities | 1 | 2024 | 82 | 0.060 |
Why?
|
| Lactates | 1 | 2023 | 93 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2024 | 257 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2022 | 178 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 42 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 3316 | 0.050 |
Why?
|
| Denmark | 1 | 2021 | 32 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2024 | 671 | 0.050 |
Why?
|
| Survivors | 1 | 2023 | 345 | 0.050 |
Why?
|
| Blood Volume | 1 | 2021 | 80 | 0.050 |
Why?
|
| Hemorrhage | 1 | 2024 | 459 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 6217 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 4706 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2024 | 581 | 0.040 |
Why?
|
| Thrombosis | 1 | 2024 | 520 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 831 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 117 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 147 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2020 | 378 | 0.040 |
Why?
|
| Prevalence | 1 | 2024 | 2406 | 0.040 |
Why?
|
| Critical Care | 1 | 2023 | 648 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2022 | 759 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2019 | 144 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 2025 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6371 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 437 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2830 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 751 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2016 | 96 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 8863 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1496 | 0.030 |
Why?
|
| Recurrence | 1 | 2019 | 1422 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1388 | 0.030 |
Why?
|
| Obesity | 1 | 2024 | 2227 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1243 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 1929 | 0.020 |
Why?
|
| Echocardiography | 1 | 2016 | 1049 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 715 | 0.020 |
Why?
|
| Hypertension | 1 | 2017 | 1287 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6033 | 0.020 |
Why?
|
HERNANDEZ-MONTFORT's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_